에 대한 최신 뉴스 Confluent (NASDAQ:CFLT) 주식

Confluent

Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. Its products include Confluent Platform; Connectors; ksqlDB and others. The company generates revenue from the sale of subscriptions and services. Geographically, it derives a majority of its revenue from the United States. The company provides solutions to Financial Services; Insurance; Retail and eCommerce; Automotive; Government and other sectors.

Short Sellers

Short Ideas

Commodities

Tech

Trading Ideas

CFLT

TSLA

전기 자동차 선두업체인 테슬라(NASDAQ:TSLA)는 최근 몇 달 동안 투자자들이 매도해야 하는 주식으로 인기가 있었다. 새로운 보고서에 따르면 이 주식은 여전히 ​​가장 인기 있는 공매도 주식들 중 하나이지만 3개월 연속 최상위권 자리를 잃었다.

테슬라는 거대 원유 기업 쉐브론에게 공매도 주식의 왕좌를 양보

Confluent Inc

<a href="https://www.globenewswire.com/Tracker?data=3IO2gUzW7Cw-Q-FQqDZQbgLiiQ15aDUo_4CXaPHofKgijz46bDoLlvDH-Fk4Z6ygMULR9uH-DRpTw3HQ5bSqk1TB6EK6oPj8GjxiZBN4BQc=">OptimizeRx Corp.</a> (the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRX#NASDAQ">OPRX</a>), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced that William J. Febbo, Chief Executive Officer (CEO) and Board Member, will be departing the Company, effective as of December 31, 2024, to pursue other opportunities. Mr. Febbo will provide the Company with advisory services through March 31, 2025. The Company's Board of Directors has retained a search firm to assist in this transition.

News

Management

OPRX

OptimizeRx CEO William Febbo To Depart, Announces Appointment Of Stephen Silvestro As Interim CEO, Effective As Of December 31, 2024

WIIM

Prestige Wealth shares are trading higher after the company announced it regained Nasdaq Compliance.

On CNBC's &#8220;Mad Money Lightning Round,&#8221; Jim Cramer recommended buying Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>). &#8220;That business is <a href="https://www.benzinga.com/quote/ANET/analyst-ratings">smoking hot,&#8221; he added</a>.
On Dec. 17, Morgan Stanley analyst Meta Marshall maintained Arista Networks with an Overweight and raised the price target from $102.5 to $118.
Cramer said Under Armour, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UA#NYSE">UA</a>) is a &#8220;great spec.&#8221; However, he recommended being careful.
On Dec. 12, Under Armor reiterated its FY25 guidance.
When asked about Texas Pacific Land Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPL#NYSE">TPL</a>), he said, &#8220;We have liked it, but it's now gone up so much. I've got to tell you, I want to hold off.&#8221;
On Nov. 6, Texas Pacific Land posted weaker-than-expected quarterly sales.
Cheniere Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LNG#NYSE">LNG</a>) is a &#8220;terrific&#8221; stock, Cramer said. "I like the LNG market now that we have President-elect Trump coming in because he's pro LNG.&#8221;
On Oct. 31, Cheniere Energy reported better-than-expected third-quarter financial results and raised its FY24 adjusted EBITDA guidance. Cheniere Energy reported quarterly earnings of $3.93 per share which beat the analyst consensus estimate of $1.87 per share. The company reported quarterly sales of $3.763 billion which beat the analyst consensus estimate of $3.729 billion.
Wells Fargo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) is a buy, the &#8220;Mad Money&#8221; host said.
Wells Fargo Bank lowered its prime rate to 7.50% from 7.75%, effective Dec. 19, 2024.
&#8220;These are really good companies, you have to buy them when they're low,&#8221; Cramer said when asked about CSX Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>).
CSX will release fourth quarter financial and operating results after the closing bell on Thursday, Jan. 23, 2025.
&#8220;You want to hold on to Eaton Corporation plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>). You know, Eaton is a buy and hold story,&#8221; Cramer said. &#8220;Do not sell, own.&#8221;
On Dec. 9, Citigroup analyst Andrew Kaplowitz maintained Eaton with a Buy and raised the price target from $394 to $440.
Price Action:
<ul>
<li>Cheniere Energy shares gained 1.4% to settle at $208.89 on Friday.</li>
<li>Arista shares rose 3.4% to close at $112.81 during the session.</li>
<li>Eaton shares rose 0.7% to settle at $338.12.</li>
<li>Texas Pacific Land shares gained 3.4% to settle at $1,133.12 on Friday.</li>
<li>Under Armour shares gained 2.9% to $7.78 on Friday.</li>
<li>Wells Fargo shares gained 2.2% to settle at $70.34 on Friday.</li>
<li>CSX shares gained 0.9% to close at $31.85.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/author/avi-kapoor">Jim Cramer Likes Walmart, Recommends Buying This &#8216;Very, Very Good&#8217; Financial Stock</a></li>
</ul>

Markets

Media

ANET

Jim Cramer Says Under Armour Is A 'Great Spec,' Recommends Buying This Big Bank Stock

CN (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CNR#TSX">CNR</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNI#NYSE">CNI</a>) announced today that its new four-year tentative collective agreements with Unifor were formally ratified by employees on Sunday, December 22, 2024. The union represents approximately 3,300 employees at CN in Canada, working in different mechanical, clerical, and intermodal functions, all covered by multiple collective agreements.

Contracts

TSX:CNR

CN Announces That Its New 4-Year Tentative Collective Agreements With Unifor Were Formally Ratified By Employees On Sunday, December 22, 2024

Novo Nordisk A/S (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) shares rose by nearly 5% in pre-market trading on Monday, as per <a href="https://pro.benzinga.com/">Benzinga Pro</a>. This follows a significant 17.8% drop on Friday, which was triggered by disappointing results from a Phase III trial of its weight-loss drug, CagriSema.
What Happened:&nbsp;The Danish pharmaceutical company experienced a €90 billion reduction in market value after the REDEFINE 1 study revealed that CagriSema&#8217;s weight-loss benefits were comparable to&nbsp;Eli Lilly&#8217;s&nbsp;Zepbound, but with poorer tolerability. The trial indicated that patients using CagriSema lost an average of 22.7% of their weight over 68 weeks, while those on a placebo lost 2.3%.
See Also:&nbsp;<a href="https://www.benzinga.com/markets/24/12/42572520/2025-housing-market-looks-like-a-year-of-struggle-for-states-like-builders-now-hold-record-inventory?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8216;2025 Housing Market Looks Like A Year Of Struggle For States Like …&#8217; – Builders Now Hold Record Inventory</a>
Talking<a href="https://www.marketwatch.com/story/novo-nordisks-27-drop-was-market-overreaction-analysts-say-fabe03c6?ref=biztoc.com"> to</a> Markets Watch, analysts at Intron Health, led by Naresh Chouhan, suggested that Friday&#8217;s market reaction was excessively severe. They highlighted&nbsp;that ongoing trials of CagriSema&nbsp;and Semaglutide might offer investors positive insights soon. This perspective has contributed to the rebound in&nbsp;Novo Nordisk&#8217;s&nbsp;stock price, as investors reassess the potential of the company&#8217;s weight-loss treatments.
Why It Matters: The recent fluctuations in&nbsp;Novo Nordisk&#8217;s&nbsp;stock have been closely watched by analysts and investors alike. According to a&nbsp;recent analysis, analysts&#8217; ratings for Novo Nordisk have varied from <a href="https://www.benzinga.com/insights/analyst-ratings/24/12/42645373/what-analysts-are-saying-about-novo-nordisk-stock">bullish to bearish </a>over the last quarter. The 12-month price targets set by analysts reveal an average target of $145.25, with a high estimate of $160.00 and a low of $105.00. This represents an 8.65% drop in the current average compared to the previous average price target of $159.00.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42635671/analyst-bullish-on-shiba-inu-sees-235-surge-despite-recent-fall?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Analyst Bullish on Shiba Inu, Sees 235% Surge Despite Recent Fall</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Shutterstock

Equities

Pre-Market Outlook

General

Novo Nordisk Rises 5% In Premarket As Analyst Dismisses Friday's 17% Plunge As Market Overreaction

Highlighting Growing Presence In Defense And AI Edge Computing Market

MTEK

Maris-Tech Secures $1M Order From U.S. Homeland Security Customer For Advanced Jupiter-Based Video Solution

Advertiser base expands by 230% in 2024, driven by acceleration in demand
Los Angeles, CA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=xYgsZKA_R_Wys6kRB9G50uyVui6MmrsOFURrrTrAL5slEiWuXpLuCR03tB87pNLORrdHrri2MEitMwgCw2SWkiEpB5Bssjro8j-G2-Q7tg8=">Thumzup Media Corporation</a> ("Thumzup" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZUP#NASDAQ">TZUP</a>), an emerging leader in social media branding and programmatic marketing solutions, is pleased to report continued strong growth in its advertiser base, which now exceeds 600 just weeks after the Company announced it surpassed 500 advertisers. This momentum and robust growth trajectory should position Thumzup as an increasingly disruptive force in social media advertising.

TZUP

Thumzup Media Corporation's Advertiser Base Expands 230% in 2024, Surpasses 600 Advertisers

&nbsp;Follows $369M Sale Of Healthcare Services Unit

NAVI

Navient To Sell Government Services Business To Gallant For ~$50M, Including $20M In Deferred Tax Assets; 1,200 Employees Transferring; Transaction Expected To Close Q1 2025 With $25M-$35M Loss Recorded In Q4 2024

Tetra Tech's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NYSE">TTEK</a>) short percent of float has fallen 7.47% since its last report. The company recently reported that it has 4.71 million shares sold short, which is 2.23% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.76 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Tetra Tech Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734961522_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Tetra Tech has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Tetra Tech's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Tetra Tech's peer group average for short interest as a percentage of float is 3.24%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

TTEK

Peering Into Tetra Tech's Recent Short Interest

Entegris's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ENTG#NYSE">ENTG</a>) short percent of float has fallen 15.58% since its last report. The company recently reported that it has 6.45 million shares sold short, which is 4.28% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.19 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Entegris Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734961517_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Entegris has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Entegris's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Entegris's peer group average for short interest as a percentage of float is 8.31%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

ENTG

Looking Into Entegris's Recent Short Interest

BHP Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHP#NYSE">BHP</a>) short percent of float has fallen 4.55% since its last report. The company recently reported that it has 10.60 million shares sold short, which is 0.42% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.78 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>BHP Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734961511_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for BHP Group has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing BHP Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, BHP Group's peer group average for short interest as a percentage of float is 4.64%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About BHP Group?

JMP Securities analyst Jonathan Wolleben reiterates Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Market Outperform and maintains $75 price target.

Price Target

Reiteration

Analyst Ratings

RYTM

JMP Securities Reiterates Market Outperform on Rhythm Pharmaceuticals, Maintains $75 Price Target

Expects to Increase Assembly Efficiency by 50%, Reducing Manual Handling, Minimizing Labor, and Enhancing Worker Safety
GARLAND, Texas, Dec. 23, 2024 /PRNewswire/ -- Massimo Group&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAMO#NASDAQ">MAMO</a>) ("Massimo"), a manufacturer and distributor of powersports vehicles and pontoon boats, today announced the successful ramp-up of its new assembly line, featuring cutting-edge robotic technology designed to streamline production and enhance quality control. This investment reinforces Massimo's commitment to meeting the needs of both its customers and investors as the company prepares for an impactful 2025.

MAMO

Massimo Motor Launches New T-Boss 560L And 760L Models With Winter-Ready Features, Enhancing Production Efficiency With Advanced Robotic Technology;

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) with a Buy and maintains $46 price target.

AVXL

D. Boral Capital Maintains Buy on Anavex Life Sciences, Maintains $46 Price Target

FPV Drone Infrared Lens Assemblies for European Defense Customer Expected to Drive $1.0-2.0 Million in Revenue in Calendar Year 2025
ORLANDO, Fla., Dec. 23, 2024 /PRNewswire/ --&nbsp;<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4330095-1&amp;h=3171632336&amp;u=https%3A%2F%2Fwww.lightpath.com%2F&amp;a=LightPath+Technologies%2C+Inc.">LightPath Technologies, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTH#NASDAQ">LPTH</a>) ("LightPath," the "Company," or "we"), a leading provider of next-generation optics and imaging systems for both defense and commercial applications, today announced that it has begun sustained delivery of infrared lens assemblies per the terms of the October 2024 Letter of Intent ("LOI") from a European defense customer for active duty use in first-person view (FPV) drone applications.
As part of the ongoing supply agreement LOI announced in October, LightPath is supplying custom lens assemblies using LightPath's BlackDiamond glass as well as the localization of its lens assembly manufacturing to LightPath's Latvia facility to ensure supply chain stability and reliability. While the initial order is for 1,300 assemblies, LightPath management expects that with several follow-on orders throughout calendar year 2025 in-line with targeted volume commitments, this customer could represent $1.0-2.0 million in annual revenue.

LPTH

LightPath Technologies Begins Sustained Delivery Of Infrared Assemblies To European Defense Customer; FPV Drone Infrared Lens Assemblies For Expected To Drive $1M-2M In Revenue In 2025

Ankaa-3 features a broad hardware redesign enabling superior performance. Enhancements across the technology stack include a new cryogenic hardware design, an overhaul of the qubit circuit layout, precise qubit frequency targeting with Alternating-Bias Assisted Annealing, and flexible gate architecture with precise controls. Ankaa-3 has achieved a 99.5% median two-qubit gate fidelity.
BERKELEY, Calif., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) ("Rigetti" or the "Company"), a pioneer in full-stack quantum-classical computing, announced today the public launch of its 84-qubit Ankaa-3 system. Ankaa-3 is Rigetti's newest flagship quantum computer featuring an extensive hardware redesign that enables superior performance. Rigetti also celebrates major two-qubit gate fidelity milestones with Ankaa-3: successfully halving error rates in 2024 to achieve a median 99.0% iSWAP gate fidelity, as well as demonstrating 99.5% median fidelity fSim gates.

RGTI

Rigetti Computing Launches 84-Qubit Ankaa-3 System; Achieves 99.5% Median Two-Qubit Gate Fidelity Milestone

JMP Securities analyst Silvan Tuerkcan reiterates enGene Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENGN#NASDAQ">ENGN</a>) with a Market Outperform and maintains $18 price target.

ENGN

JMP Securities Reiterates Market Outperform on enGene Holdings, Maintains $18 Price Target

Robust October and November 2024 results driven by the continued success of FlexShopper's direct-to-consumer and business-to-business growth strategies
Based on strong October and November 2024 performance, management expects the fourth quarter of 2024 to exceed financial results for the fourth quarter of 2023
BOCA RATON, Fla., Dec. 23, 2024 (GLOBE NEWSWIRE) -- FlexShopper, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/FPAY#NASDAQ">FPAY</a>), a prominent national online lease-to-own retailer and payment solutions provider, today announced record initial holiday season financial results, as the Company benefits from the continued success of its direct-to-consumer (DTC) and business-to-business (B2B) growth strategies. For the first two months of the 2024 fourth quarter, compared to the same two-month period in 2023, lease gross revenue increased 15%, and lease net revenue increased over 25%, as bad debt expense, as a percent of gross revenue declined by 600 basis points. As a result, lease gross profit increased 51% for the first two months of the 2024 fourth quarter, while lease marketing expense has declined over 40% for the same period. New loan originations increased over 34% versus the same two-month period last year.

Guidance

FPAY

FlexShopper Announces Record Q4 Start With Lease Gross Revenue Up 15%, Net Revenue Up 25%, And Gross Profit Up 51% YoY; Marketing Expenses Down 40%, New Loan Originations Up 34%

HOVR

Horizon Aircraft shares are trading higher after the company received an $8.4 million investment.

Singular Genomics Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OMIC#NASDAQ">OMIC</a>) ("Singular Genomics" or the "Company"), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement whereby an affiliate of Deerfield Management Company, L.P. will acquire Singular Genomics in an all-cash transaction for $20.00 per share.
The $20.00 per share represents 254% premium to the last closing share price for Singular's common stock prior to the September 12, 2024 public disclosure of Deerfield's initial acquisition proposal.

OMIC

Singular Genomics Enters Into Agreement To Be Acquired By Deerfield For $20 In Cash per Share

JPMorgan analyst Pinjalim Bora raised the firm's price target on Confluent (CFLT) to $38 from $35 and keeps an Overweight rating on the shares. The...

Confluent price target raised to $38 from $35 at JPMorgan

C3.ai, PagerDuty in focus as JP Morgan changes ratings on enterprise software stocks

Allspring Small Company Growth Fund Q3 2024 Commentary

Truist analyst Miller Jump raised the firm's price target on Confluent (CFLT) to $35 from $32 and keeps a Buy rating on the shares as part of a bro...

Confluent price target raised to $35 from $32 at Truist

Confluent: Unlocking The Potential Of AI

Mizuho raised the firm's price target on Confluent (CFLT) to $35 from $31 and keeps an Outperform rating on the shares as part of a 2025 outlook fo...

Confluent price target raised to $35 from $31 at Mizuho

Atlassian, Datadog outperform on cloud migrations: Mizuho

Truist Financial analyst Miller Jump maintained a Buy rating on Confluent (CFLT – Research Report) yesterday and set a price target of $35.00. The ...

Truist Financial Remains a Buy on Confluent (CFLT)

Confluent: Data Show Big Downside

Stifel analyst Brad Reback raised the firm's price target on Confluent (CFLT) to $37 from $34 and keeps a Buy rating on the shares. After a bumpy s...

Confluent price target raised to $37 from $34 at Stifel

ATKR

BWIN

CYBR

DDOG

EGHT

ESTC

FOUR

FROG

FTNT

GTLB

MSFT

MYRG

PATK

PLTR

RYAN

SMCI

TEAM

Press Releases

Confluent to Present at Upcoming Investor Conferences

Confluent Acquires WarpStream to Advance Next-Gen BYOC Data Streaming

Confluent Supercharges Apache Flink® Offering with New Developer Tools and Enterprise-Ready Security

Confluent Launches OEM Program to Help Partners Quickly and Confidently Grow Their Business with Data Streaming

Confluent Invests in Onibex and Psyncopate Amid Increased Demand for Complete Data Streaming Platforms

Confluent to Announce Third Quarter 2024 Financial Results on October 30, 2024

Confluent Announces Third Quarter 2024 Financial Results

Oscilar Launches Revolutionary Device and Behavioral Intelligence Solution to Combat AI-Powered Fraud

New Confluent Platform for Apache Flink Makes It Easy to Manage and Secure High-Performance Stream Processing On-Premises

Altair Engineering Inc. - Class A Common Stock

Altair Engineering

AppFolio

Aurora Innovation, Inc. - Class A Common Stock

Aurora Innovation

Aspen Technology

BILL Holdings

Bentley Systems, Incorporated - Class B Common Stock

Bentley Systems

CCC Intelligent Solutions Holdings Inc. - Common Stock

CCC Intelligent Solutions

Dropbox

DocuSign

Dynatrace

Guidewire Software

Informatica

Klaviyo

Manhattan Associates, Inc. - Common Stock

Manhattan Associates

NICE Ltd - American Depositary Shares each representing one Ordinary Share

NICE

Nutanix

Procore Technologies

Pegasystems

Smartsheet

SoundHound AI, Inc. - Class A Common Stock

SoundHound AI

SPS Commerce

ServiceTitan, Inc. - Class A Common Stock

ServiceTitan

Unity Software

Vertex

Stifel

Mizuho

Truist Securities

JP Morgan

Barclays

전기 자동차 선두업체인 테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)는 <a href="https://www.benzinga.com/short-sellers/24/04/38213443/tesla-stock-down-30-in-2024-investors-continue-to-short-bet-against-ev-leader-new-data-reveals" target="_blank" rel="noopener">최근 몇 달 동안</a> 투자자들이 매도해야 하는 주식으로 인기가 있었다.
새로운 보고서에 따르면 이 주식은 여전히 ​​가장 인기 있는 공매도 주식들 중 하나이지만 3개월 연속 최상위권 자리를 잃었다.
어떤 일이 있었나요 (What Happened): 테슬라는 <a href="https://www.benzinga.com/news/earnings/24/04/38390883/tesla-q1-earnings-highlights-ev-giant-misses-wall-street-estimates-makes-cost-cuts-invests-in-ai-sp">1분기 재무 성과</a> 및 생산 및 인도 숫자가 분석가들의 예상을 밑돌았다.
이 주식은 배송이 감소하고 투자자들이 미래 방향에 대해 불안하고 걱정하면서 인기 있는 공매도 주식이었다.
헤이즐트리(Hazeltree)의 새로운 <a href="https://hazeltree.com/lp/hazeltree-monthly-shortside-report/">보고서</a>에 따르면 테슬라는 공매도가 가장 활발한 주식 중 하나이다. 테슬라는 4월 헤이즐트리 공매도 집중도 보고서(Hazeltree Shortside Crowdedness Report)에서 99점 만점에 97점으로 2위를 차지했다.
이 점수로 테슬라는 대형주 중에서 2위를 차지했다.
테슬라보다 앞서 있는 순위는 99점을 획득한 쉐브론(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>)이다. 쉐브론도 3월 보고서에서 99점을 기록했지만 단독으로 리더보드 1위를 차지한 것은 이번이 처음이다. 테슬라는 1월, 2월, 3월에 99점을 받아 1위에 올랐다.
<a href="https://www.benzinga.com/pro/feature/newsfeed?gspk=bHVrZWphY29iaTUzNDg&amp;gsxid=tdEE0VrK8Jeg&amp;ref=lukejacobi5348">벤징가 프로(Benzinga Pro)</a>의 데이터에 따르면 현재 테슬라 주식의 3.8%가 공매도 상태이고, 쉐브론 주식의 2.8%가 공매도 상태이다.
석유 주식은 단기 거래 아이디어로 관심을 끌 수 있다. 거대 석유회사 엑슨모빌(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>)은 대형주 중에서 89점으로 3위를 차지했다.
단기매도로 관심이 높아지는 석유주는 엑슨모빌(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>)이 대형주 중에서 89점을 받아 3위를 기록했다.
헤이즐트리는 중형주 중에서 각각 99점을 받아 공매도 부담도를 가장 많이 받은 기업으로 데이포스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAY#NYSE">DAY</a>)와 컨플루언트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>)를 선정했다. 지난달 1위 기업인 웨이페어(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>)는 5위로 내려앉았다.
앞선 보고서와는 달리, 이번 보고서에는 공매도 부담도가 높은 99점을 받은 소형주 기업이 단 한 개 뿐이었다. 이 유일한 기업은 풋락커(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>)였다.
관련 링크: <a href="https://www.benzinga.com/markets/equities/24/05/38823265/short-sellers-run-scared-as-meme-stocks-roar-why-high-short-interest-stocks-keep-ripping">공매도자들의 공포: 왜 대표적인 공매도주인 ‘밈&#8217; 주식들은 계속 급등했을까</a>
왜 중요한가 (Why It&#8217;s Important): 테슬라는 만점인 99점을 잃어 2위로 떨어졌지만, 이 주식은 여전히 ​​공매도자들에게 인기 있다.
&#8216;빅쇼트&#8217;로 유명한 투자자 대니 모세스(Danny Moses)는 최근 테슬라 주가가 <a href="https://www.benzinga.com/markets/equities/24/05/38807245/big-short-fame-investor-expects-elon-musks-tesla-shares-to-plunge-70-people-are-going-to-start-t">70% 하락</a>하여 50달러가 될 것이라고 생각한다고 밝혔다.
"핵심 사업에서는 모든 것이 무너지고 있다. 그는 모든 사람에게 로봇택시와 AI, 자율성을 강조하고 있다. 자동차 회사라면 정말 &#8216;보여달라&#8217;는 이야기가 되었고, 시간이 지나면서 이 회사가 어떻게 될지에 대해 사람들이 인내심을 잃기 시작할 것&#8221;이라고 모세스가 말했다.
테슬라는 수년간 투자자들이 전기 자동차와 일론 머스크의 성공에 많은 반대를 하면서 <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36672843/tesla-loses-most-shorted-crown-to-this-magnificent-7-stock-as-ev-giants-skeptics-ta" target="_blank" rel="noreferrer noopener">인기 있는 공매도 대상</a>이었다. 이 테슬라 CEO는 공매도에 대해 목소리를 높이고 이 회사의 주가가 종종 시장을 능가했기 때문에 여러 번 <a href="https://www.benzinga.com/markets/equities/23/11/35862679/elon-musk-blasts-shorts-as-gluttons-for-punishment-after-sen-tommy-tuberville-discloses-bearish-" target="_blank" rel="noreferrer noopener">경고</a>를 보냈다.
TSLA, CVX 주가 움직임: 테슬의 주식은 2.01% 하락한 173.99달러에 마감했다. 지난 52주 동안의 주식 가격 변동폭은 138.80달러에서 299.29달러였다. 테슬라 주식은 지난 1년간 5.0% 상승했지만, 올해는 29.7% 하락했다.
쉐브론의 주식 수요일 0.34% 하락한 163.05달러에 마감했다. 지난 52주 동안의 주식 가격 변동폭은 139.62달러에서 171.70달러였다. 쉐브론 주식은 지난 1년간 34.0% 상승했고, 올해는 9.0% 상승다.
읽어보기: <a href="https://www.benzinga.com/news/24/05/38854237/gamestop-amc-surge-burns-short-sellers-this-hedge-fund-may-have-been-on-the-right-side-of-the-trade">게임스탑, AMC 주식 폭등으로 인한 공매도자들의 손실</a>
사진: William Potter on Shutterstock

Comments

Confluent

뉴스

에 대한 최신 뉴스 Confluent (NASDAQ:CFLT) 주식

목요일, 5월 16, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌